CELLCURA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

99302295

Mark type

Stylized text

Filed

25 Jul 2025

Published for opposition

24 Feb 2026

Attorney of record

Cy Bates

Goods and services

• Class 005 — Pharmaceuticals: Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers

Owner

• Cellcura Sciences, Inc., Lehi, UT, US
• Cellcura Sciences, Inc., Lehi, UT, US

Prosecution history

• 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Feb 2026 — PUBLISHED FOR OPPOSITION
• 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 02 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 20 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 20 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 20 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Dec 2025 — NON-FINAL ACTION E-MAILED
• 12 Dec 2025 — NON-FINAL ACTION WRITTEN
• 11 Dec 2025 — ASSIGNED TO EXAMINER
• 25 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 25 Jul 2025 — APPLICATION FILING RECEIPT MAILED
• 25 Jul 2025 — NEW APPLICATION ENTERED